Kala Bio (KALA) Long-Term Investments (2019 - 2022)

Kala Bio has disclosed Long-Term Investments across 4 years of filings, most recently posting $7.8 million for Q1 2022.

• In Q1 2022, Long-Term Investments rose 25.82% year-over-year to $7.8 million; the TTM figure through Mar 2022 stood at $7.8 million (up 25.82% YoY), while the FY2021 annual figure was $9.6 million, up 54.01% from the prior year.
• Long-Term Investments came in at $7.8 million for Q1 2022 at Kala Bio, down from $9.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $11.0 million in Q3 2021 to a low of $2.7 million in Q3 2020.
• Average Long-Term Investments over 4 years is $6.1 million, with a median of $6.2 million recorded in 2021.
• Year-over-year, Long-Term Investments dropped 10.37% in 2020 and jumped 310.52% in 2021.
• Over 4 years, Long-Term Investments stood at $3.8 million in 2019, then jumped by 64.61% to $6.2 million in 2020, then soared by 54.01% to $9.6 million in 2021, then declined by 18.55% to $7.8 million in 2022.
• Per Business Quant data, the three most recent Long-Term Investments figures were $7.8 million in Q1 2022, $9.6 million in Q4 2021, and $11.0 million in Q3 2021.